Ryan Likes - 13 Sep 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Operating Officer
Signature
/s/ Dale S. Bergman as attorney-in-fact for Ryan Likes
Issuer symbol
OCEL
Transactions as of
13 Sep 2022
Transactions value $
$0
Form type
3
Filing time
20 Sep 2022, 16:05:17 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrants to Purchase Common Stock 13 Sep 2022 Common Stock, par value $0.001 24,000,000 $0.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Warrants vest in 24 equal monthly installments of 1,000,000 shares each on the first day of each calendar month commencing August 1, 2022.

Remarks:

Exhibit List - Exhibit 24 Power of attorney